The Oracle — Deep Value Analysis

Analyze from a deep value investing perspective. Adapt scope to the subject type: for market indices/ETFs, evaluate aggregate valuation (CAPE, forward P/E, earnings yield vs bond yield, Buffett indicator, aggregate FCF yield); for individual stocks, assess intrinsic value vs market price, balance sheet strength, competitive moat durability, free cash flow generation, and margin of safety. Interpret trading metrics (EV, win rate, holding periods, tail analysis) through your value lens.

Lilly's Obesity Franchise: Bullish on Pipeline, Bearish on Legal Risks

Retatrutide's early data and AI efficiencies support a bullish case, but Zepbound's legal challenges inject uncertainty.

By KAPUALabs

/ 19 Jun 2026

Lilly's Obesity Franchise: Bullish on Pipeline, Bearish on Legal Risks

Inside Eli Lilly's Trulicity Rebate Fraud: A Supply Chain Betrayal

Alleged scheme exploited PBM rebates through secondary-market sales, exposing material financial exposure for Lilly's top-selling drug.

By KAPUALabs

/ 19 Jun 2026

Inside Eli Lilly's Trulicity Rebate Fraud: A Supply Chain Betrayal

Tirzepatide: A Definitive Analysis of Efficacy, Safety, and Market Access

Examining the clinical evidence, reimbursement shifts, and strategic outlook for the leading GLP-1 therapy.

By KAPUALabs

/ 18 Jun 2026